Irradiation may help CAR-T cell therapy work better against solid tumors

byThe Mount Sinai HospitalCAR-T cells (brown, arrowheads) infiltrating solid tumors. Left: unirradiated (0 Gy). Right: after focal irradiation (8 Gy). Credit:Nature Cancer(2026). DOI: 10.1038/s43018-0

Updated on: August 13,2026

Irradiation may help CAR-T cell therapy work better against solid tumors

byThe Mount Sinai HospitalCAR-T cells (brown, arrowheads) infiltrating solid tumors. Left: unirradiated (0 Gy). Right: after focal irradiation (8 Gy). Credit:Nature Cancer(2026). DOI: 10.1038/s43018-0

Updated on:August 13,2026

Cancer care workforce gap could reach 100 million by 2050, report warns

byLa Trobe UniversityProfessor Andrew Scott, from Melbourne's Olivia Newton-John Cancer Research Institute affiliated with La Trobe University as the School of Cancer Medicine, is the only Austral

Updated on: August 13,2026

Cancer care workforce gap could reach 100 million by 2050, report warns

byLa Trobe UniversityProfessor Andrew Scott, from Melbourne's Olivia Newton-John Cancer Research Institute affiliated with La Trobe University as the School of Cancer Medicine, is the only Austral

Updated on:August 13,2026

Children's brain tumors may spread faster when microglia build invasion-friendly scaffolding

by Anna Persson,Karolinska InstitutetCredit: Karolinska InstitutetResearchers at the Institute of Environmental Medicine (IMM), Karolinska Institutet, have identified a possible mechanism behind the s

Updated on: August 12,2026

Children's brain tumors may spread faster when microglia build invasion-friendly scaffolding

by Anna Persson,Karolinska InstitutetCredit: Karolinska InstitutetResearchers at the Institute of Environmental Medicine (IMM), Karolinska Institutet, have identified a possible mechanism behind the s

Updated on:August 12,2026

Study on circulating tumor DNA shows clear benefits

by Anne Vetter, Nationales Centrum für Tumorerkrankungen (NCT/UCC) DresdenCredit: Michael Kretzschmar, UKDAfter surgery for colon cancer, many patients face the question of whether follow-up chemother

Updated on: August 12,2026

Study on circulating tumor DNA shows clear benefits

by Anne Vetter, Nationales Centrum für Tumorerkrankungen (NCT/UCC) DresdenCredit: Michael Kretzschmar, UKDAfter surgery for colon cancer, many patients face the question of whether follow-up chemother

Updated on:August 12,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on: August 11,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on:August 11,2026

Study of prostate cancer in Brazil reveals racial inequalities in diagnosis and treatment

by Maria Eduarda Ledo de Abreu, D'Or Institute for Research and EducationCredit: Anna Tarazevich from PexelsThe largest real-world study ever conducted on prostate cancer in Brazil analyzed data f

Updated on: August 11,2026

Study of prostate cancer in Brazil reveals racial inequalities in diagnosis and treatment

by Maria Eduarda Ledo de Abreu, D'Or Institute for Research and EducationCredit: Anna Tarazevich from PexelsThe largest real-world study ever conducted on prostate cancer in Brazil analyzed data f

Updated on:August 11,2026

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who

Updated on: August 10,2026

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who

Updated on:August 10,2026

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa

Updated on: August 08,2026

Shrunken genomes may drive rapid cancer evolution and poor outcomes

by Thomas Deane,Trinity College DublinCredit: Pixabay/CC0 Public DomainResearchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor pa

Updated on:August 08,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on: August 08,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on:August 08,2026

Screening with a multi-cancer blood test reduced the most advanced cancers

by Louise Vennells,University of ExeterNHS Galleri study nurse with participant. Credit: University of ExeterA large-scale trial looking into the use of a blood test to see if it can help the NHS dete

Updated on: August 08,2026

Screening with a multi-cancer blood test reduced the most advanced cancers

by Louise Vennells,University of ExeterNHS Galleri study nurse with participant. Credit: University of ExeterA large-scale trial looking into the use of a blood test to see if it can help the NHS dete

Updated on:August 08,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on: August 06,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on:August 06,2026

Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death

byDana-Farber Cancer InstituteCredit: Anna Tarazevich from PexelsHigh-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-recep

Updated on: August 05,2026

Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death

byDana-Farber Cancer InstituteCredit: Anna Tarazevich from PexelsHigh-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-recep

Updated on:August 05,2026